Medicine and Dentistry
Cystic Fibrosis
70%
Pneumothorax
67%
Patient with Cystic Fibrosis
61%
Forced Expiratory Volume
44%
Transbronchial Biopsy
33%
Procalcitonin
33%
African Trypanosomiasis
33%
Hemoptysis
33%
Prospective Cohort Study
33%
Azithromycin
33%
Immunocompromised Patient
13%
Antibiotics
11%
Trypanosoma Brucei
11%
Melarsoprol
11%
Lung Barotrauma
9%
Disease
8%
Mucociliary Clearance
8%
Intensive Care
8%
Genetic Disorder
8%
Health Care Provider
8%
Obstruction
8%
Pathogen
8%
Pneumonia
8%
Lung Infection
8%
Infection
8%
Antibiotic Therapy
7%
Pathophysiology
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
100%
Pseudomonas
42%
Prospective Cohort Study
33%
Quinolone
33%
Azithromycin
33%
Procalcitonin
33%
Heme Oxygenase 1
33%
African Trypanosomiasis
33%
Nitric Oxide
33%
Normal Human
17%
Pseudomonas aeruginosa
14%
Trypanosoma Brucei Rhodesiense
11%
Antibiotics
11%
Asplenia
11%
Melarsoprol
11%
Diarrhea
8%
Side Effect
8%
Reactive Oxygen Metabolite
8%
Nausea
8%
Antibiotic Agent
7%
Human
6%
Flow Cytometry
5%
Pathogenicity
5%
Keyphrases
Pseudomonas Quinolone Signal
33%
Evidence-informed
33%
Forced Expiratory Volume in 1 Second (FEV1)
33%
Cystic Fibrosis
33%
Vest
33%
AE-IPF
33%
Splenectomized Patient
33%
Delayed Pneumothorax
33%
Lung Function
33%
Inhaled Colistin
16%
Pulmonary Barotrauma
13%
Saccharin Transit Time
8%
Melarsoprol
8%
Asplenia
8%
Splenectomized
8%
Refection
8%
Safari
8%
Iatrogenic Pneumothorax
8%
Variability Measure
7%
Pulmonary Therapy
6%
Chronic Pulmonary Inflammation
6%
Food-based Dietary Guidelines
5%
Feeding Assessment
5%
Enteral Feeding Tube
5%
Decline Rate
5%
Baseline Period
5%
